MAP2K5 and malignant colon neoplasm: We have previously shown that ERK5 activation promotes IκB phosphorylation, targeting IκB for degradation, and leading to increased NF-κB nuclear translocation and transcriptional activity, establishing a novel axis by which MEK5/ERK5 signaling contributes to colon cancer onset, progression and metastasis [11].